Meet us at Booth 212 to learn more about RNAscope™ technology to analyze the tumor microenvironment

Attend the RNAscope™ technology talk during the Immuno-Oncology Targets Session:

State-of-the-Art Tissue Expression Analysis Platform for Multiplexed Immuno-Oncology Target and Biomarker Development

Presenter: Christopher Bunker, PhD, Advanced Cell Diagnostics, Inc.

Wednesday June 14, 5:25 PM

http://www.worldpreclinicalcongress.com/Immuno-Oncology-Targets/#Day2